Carolina Pavon, APRN
Family · Fort Myers, FLNPI 1053951996
Payments from drug & device makers
Across 54 payments — averaging $78.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$585
- Lilly USA, LLC$466
- AbbVie$452
- Merck$272
- Boehringer Ingelheim$261
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$250
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,223100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 9 | $585 |
| Lilly USA, LLC | 5 | $466 |
| AbbVie | 4 | $452 |
| Merck | 3 | $272 |
| Boehringer Ingelheim | 3 | $261 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $250 |
| Insmed, Inc. | 2 | $240 |
| Amgen | 2 | $217 |
| Astellas Pharma US Inc | 1 | $140 |
| Neurocrine Biosciences, Inc. | 1 | $138 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| Novo Nordisk | 1 | $120 |
| Pfizer | 2 | $115 |
| Boston Scientific | 2 | $112 |
| Corcept Therapeutics | 1 | $101 |
| Axsome Therapeutics, Inc. | 1 | $97 |
| Xeris Pharmaceuticals, Inc. | 1 | $95 |
| United Therapeutics Corporation | 1 | $86 |
| Novartis | 3 | $60 |
| Blue Earth Diagnostics | 1 | $36 |
| Myriad Genetic Laboratories, Inc. | 2 | $36 |
| Tolmar, Inc. | 1 | $30 |
| GSK | 1 | $22 |
| Radius Health, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,223 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 44 | $504 |
| Cephalexin | 28 | $205 |
| Dexamethasone | 26 | $176 |
| Doxycycline Hyclate | 32 | $174 |
| Azithromycin | 32 | $144 |
| Ciprofloxacin Hcl | 17 | $137 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $99 |
| Prednisone | 26 | $26 |
| Naproxen | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Myers
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.